Skin cancer in Australian heart transplant recipients

Journal of the American Academy of Dermatology

Volumn 40, Issue 1, 1999, Pages 27-34

  Ong, C S ^a   Keogh, A M ^a   Kossard, S ^a   Macdonald, P S ^a   Spratt, P M ^a  

^a SKIN AND CANCER FOUNDATION AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN; HLA DR7 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; BASAL CELL CARCINOMA; BOWEN DISEASE; CANCER INCIDENCE; CANCER PREVENTION; CAUCASIAN; CHILD; FEMALE; HEART TRANSPLANTATION; HLA TYPING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; RECIPIENT; SKIN CANCER; SQUAMOUS CELL CARCINOMA;

EID: 0032973963     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(99)70525-6     Document Type: Article

References (55)

1. I. Penn Malignancy Surg Clin North Am 74 1994 1247 1257
2. AGR. Sheil Malignancy in organ transplant recipients Transplant Proc 28 1996 1162
3. RE Kwa K Campana RL. Moy Biology of cutaneous squamous cell carcinoma J Am Acad Dermatol 26 1992 1 26
4. AK Gupta CJ Cardella HF. Haberman Cutaneous malignant neoplasms in patients with renal transplants Arch Dermatol 122 1986 1288 1293
5. FC Koranda EM Dehmel G Kahn I. Penn Cutaneous complications in immunosuppressed renal homograft recipients JAMA 229 1974 419 424
6. S Euvrard J Kanitakis C Poutell-Noble F Disant G Dureau J Finaz de Villaine Aggressive squamous cell carcinomas in organ transplant recipients Transplant Proc 27 1995 1767 1768
7. S Euvrard J Kanitakis C Pouteil-Nobel G Dureau JL Touraine M Faure Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation J Am Acad Dermatol 33 1995 222 229
8. AGR Sheil APS Disney TH Mathew BER Livingston AM. Keogh Lymphoma incidence, cyclosporine, and the evolution and major impact of malignancy following organ transplantation Transplant Proc 29 1997 825 827
9. A Green D Battistutta V Hart D Leslie D Weedon the Nambour Study Group. Skin cancer in a subtropical Australian population: incidence and lack of association with occupation Am J Epidemiol 144 1996 1034 1040
10. R Marks M Staples GG. Giles Trends in non-melanocytic skin cancer treated in Australia: the second national survey Int J Cancer 53 1993 585 590
11. PL Jelfs G Giles D Shugg M Coates G Durling P Fitzgerald Cutaneous malignant melanoma in Australia, 1989 Med J Aust 161 1994 182 187
12. JN Bouwes Bavinck DR Hardie A Green S Cutmore A MacNaught B O’Sullivan The risk of skin cancer in renal transplant recipients in Queensland, Australia Transplantation 61 1996 715 721
13. A Espana P Redondo AL Fernandez M Zabala J Herreros R Llorens Skin cancer in heart transplant recipients J Am Acad Dermatol 32 1995 458 465
14. P Jensen OPF Clausen O Geiran S Simonsen A Relbo S Hansen Cutaneous complications in heart transplant recipients in Norway 1983-1993 Acta Derm Venereol (Stockh) 75 1995 400 403
15. HL Mihalov P Gattuso K Abraham EW Holmes V. Reddy Incidence of post-transplant malignancy among 674 solid organ transplant recipients at a single centre Clin Transplant 10 1996 248 255
16. BK Walder MR Robertson D. Jeremy Skin cancer and immunosuppression Lancet 2 1971 1282 1283
17. D Czarnecki N Collins C Meehan T O’Brien S Leahy CA Nash Squamous cell carcinoma in southern and northern Australia Int J Dermatol 31 1992 492 493
18. R Marks D Jolley AP Dorevitch TS. Selwood The incidence of non-melanocytic skin cancers in an Australian population: results of a five-year prospective study Med J Aust 150 1989 475 478
19. A Green G Beardmore V Hart D Leslie R Marks D. Staines Skin cancer in a Queensland population J Am Acad Dermatol 19 1988 1045 1052
20. W Qunibi M Akhtar K Sheth HE Ginn O Al-Furayh EB DeVol Kaposi’s sarcoma: the most common tumor after renal transplantation in Saudi Arabia Am J Med 84 1988 225 232
21. MH Greene TI Young WH Clark Jr. Malignant melanoma in renal-transplant recipients Lancet 1 1981 1196 1199
22. RL Nixon AP Dorevitch R. Marks Squamous cell carcinoma of the skin: accuracy of clinical diagnosis and outcome of follow-up in Australia Med J Aust 144 1986 235 239
23. D Czarnecki M Staples A Mar G Giles C. Meehan Metastases from squamous cell carcinoma of the skin in Southern Australia Dermatology 189 1994 52 54
24. R Moller F Reyman K. Hou-Jensen Metastases in dermatological patients with squamous cell carcinoma Arch Dermatol 115 1979 703 705
25. RD. Granstein Photoimmunology TB Fitzpatrick AZ Eisen K Wolff IM Freedberg KF Austen Dermatology in general medicine. 1993 McGraw-Hill New York 1638 1650
26. F Aubry B. MacGibbon Risk factors of squamous cell carcinoma of the skin: a case-control study in the Montreal region Cancer 55 1985 907 911
27. MR Karagas TA Stukel R Greenburg JA Baron LA Mott RS Stern Risk of susequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer JAMA 267 1992 3305 3310
28. F Grodstein FE Speizer DJ. Hunter A prospective study of incident squamous cell carcinoma of the skin in the Nurses Health Study J Natl Cancer Inst 87 1995 1061 1066
29. ED Wynder D. Hoffman Experimental tobacco carcinogenesis Adv Cancer Res 8 1964 249 453
30. JB Smith NA. Fenske Cutaneous manifestations and consequences of smoking J Am Acad Dermatol 34 1996 717 732
31. NA Zeid HK Muller Tobacco smoke condensate cutaneous carcinogenesis: changes in Langerhans’ cells and tumour regression Int J Exp Pathol 76 1995 75 83
32. PG Holt D. Keast Environmentally induced changes in immunological function: acute and chronic effects of inhalation of tobacco smoke and other atmospheric contaminants in man and experimental animals Bacteriol Rev 41 1977 205 216
33. M Ferson A Edwards A Lind GW Milton P. Hersey Low natural killer-cell activity and immunoglobulin levels associated with smoking in human subjects Int J Cancer 23 1979 603 609
34. GN King CM Healy MT Glover JT Kwan DM Williams IM Leigh Increased prevalence of dysplastic and malignant lip lesions in renal-transplant recipients N Engl J Med 332 1995 1052 1057
35. D Czarnecki A Lewis I Nicholson B. Tait Multiple basal cell carcinomas and HLA frequencies in southern Australia J Am Acad Dermatol 24 1991 559 561
36. D Czarnecki A Lewis I Nicholson B Tait C. Nash HLA-DR1 is not a sign of poor prognosis for the development of multiple basal cell carcinomas J Am Acad Dermatol 26 1992 717 719
37. MT Glover J Bodmer W Bodmer LJ Kennedy J Brown C Navarrete HLA antigen frequencies in renal transplant recipients and non-immunosuppressed patients with non-melanoma skin cancer Eur J Cancer 29A 1993 520 524
38. JN Bouwes Bavinck AMM Kootte FJ Van der Woude JP Vandenbroucke BJ Vermeer FHJ. Claas On a possible protective effect of HLA-A11 against skin cancer and keratotic skin lesions in renal transplant recipients J Invest Dermatol 97 1991 269 272
39. D Czarnecki F Watkins S Leahy D Dyall-Smith A Lewis I Nicholson Skin cancers and HLA frequencies in renal transplant recipients Dermatology 185 1992 9 11
40. JN Bouwes Bavinck FHJ Claas DR Hardie A Green BJ Vermeer IR. Hardie Relation between HLA antigens and skin cancer in renal transplant recipients in Queensland, Australia J Invest Dermatol 108 1997 708 711
41. JN Bouwes Bavinck BJ Vermeer FJ van der Woude JP Vandenbroucke M Geziena GMT Schreuder Relation between skin cancer and HLA antigens in renal transplant recipients N Engl J Med 325 1991 843 848
42. DB Czarnecki A Lewis I Nicholson B. Tait Multiple nonmelanoma skin cancer associated with HLA DR7 in Southern Australia Cancer 68 1991 439 440
43. JS Schroeder SZ Gao EL Alderman SA Hunt I Johnstone DB Boothroyd A preliminary study of diltiazem in the prevention of coronary artery disease in heart transplant recipients N Engl J Med 328 1993 164 170
44. K Wagner H-H. Neumayer Influence of the calcium antagonist diltiazem on delayed graft function in cadaveric kidney transplantation: results of a 6 month follow-up Transplant Proc 19 1987 1353 1357
45. J Wahlberg E Hanas C Bergstrom B Fellstrom I Skarp-Orberg L. Frodin Diltiazem treatment with reduced dose of cyclosporine in renal transplant recipients Transplant Proc 24 1992 311 312
46. MA McMillen T Lewis BM Jaffe RB. Wait Verapamil inhibition of lymphocyte proliferation and function in vitro J Surg Res 39 1985 76 80
47. GE Kelly W Meikle AGR. Sheil Effects of immunosuppressive therapy on the induction of skin tumours by ultraviolet irradiation in hairless mice Transplantation 44 1987 429 434
48. AEM Taylor S. Shuster Skin cancer after renal transplantation: the causal role of azathioprine Acta Derm Venereol (Stockh) 72 1992 115 119
49. L Lennard S Thomas CI Harrington JL. Maddocks Skin cancer in renal transplant recipients is associated with increased concentrations of 6-thioguanine nucleotide in red blood cells Br J Dermatol 113 1985 723 729
50. VJ Hemmens DE. Moore Photochemical sensitisation by azathioprine and its metabolites: II. Azathioprine and nitroimidazole metabolites Photochem Photobiol 43 1986 257 262
51. KS Servilla DK Burnham RA. Daynes Ability of cyclosporine to promote the growth of transplanted ultraviolet radiation induced tumours in mice Transplantation 44 1987 291 295
52. D Shuttleworth R Marks PJA Griffin JR. Salaman Epidermal dysplasia and cyclosporine therapy in renal transplant patients: a comparison with azathioprine Br J Dermatol 120 1989 551 554
53. MH Bunney EC Benton BB Barr JW Smith JL Anderton JA. Hunter The prevalence of skin disorders in renal allograft recipients receiving cyclosporin A compared with those receiving azathioprine Nephrol Dial Transplant 5 1990 379 382
54. SA Gruber K Gillingham RB Sothern E Stephanian AJ Matas DL. Dunn De novo cancer in cyclosporine-treated and non-cyclosporine-treated adult primary renal allograft recipients Clin Transplant 8 1994 388 395
55. G Theil A Bock M Spondlin FP Brunner M Mihatsch T Rufli Long-term benefits and risks of Cyclosporin A (Sandimmun): an analysis at 10 years Transplant Proc 26 1994 2493 2498